| Posted: May 31, 2012 | |
Under the influence of magnetic drugs |
|
| (Nanowerk News) For more than three decades scientists have been investigating magnetic nanoparticles as a method of drug delivery. Now by combining three metals - iron, gold and platinum - pharmacists at the University of Sydney believe they have discovered a method for magnetically directing drugs through the body. | |
| The discovery has been published online today in the international journal Inorganica Chimica Acta. | |
| Led by Dr Nial Wheate, a team of scientists from the Faculty of Pharmacy, along with collaborators in Scotland, have developed a new anticancer drug that has an iron oxide core as small as 5 nanometres in size. | |
 |
|
| Dr Nial Wheate: "This discovery means we can potentially direct where in the body a drug goes." | |
| "We coated this iron oxide core in a protective layer of gold before cisplatin, a platinum drug that revolutionised the treatment of testicular cancer, was attached to the gold coating using spaghetti-like strings of polymer." | |
| The important thing about this new drug, says Dr Wheate, is the ability of its iron core to move under the influence of a magnet; similar to the iron filing experiments many people have performed in science classes. | |
| "When we take regular medication it is difficult to manage where it goes. But this discovery means we can potentially direct exactly where in the human body a drug goes. We can move it to the desired cancer tumour site using powerful magnetic fields. Otherwise, a strong magnet could be implanted into a tumour, and draw the drug into the cancer cells that way." | |
| The technology was demonstrated when the team grew cancer cells in plates in the lab. When they placed a magnet under the plates, the drug affected and killed only those cells growing near the magnet, leaving the others unharmed, says Dr Wheate. | |
| "Many of the side-effects associated with chemotherapy occur because the drugs spread throughout the body, killing healthy organs as well as cancers. | |
| "Ultimately, this technology could greatly reduce or even eliminate the severe side-effects that people associate with chemotherapy such as hair loss, nausea, vomiting, low red blood cells and an increased risk of infection." | |
| This new drug technology could also be used to treat a range of cancers that have not been treatable with conventional platinum drugs, like prostate cancer. | |
| Platinum drugs are one of the most regularly used family of agents in chemotherapy and include cisplatin, carboplatin and oxaliplatin. |
| Source: University of Sydney |
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: